170799-33-4 Usage
Molecular structure
The compound has a complex chemical structure with an isoindoline-1,3-dione core and a 2-(3-(dibenzylamino)-2-hydroxypropyl) side chain attached.
Potential use
It can be used as a building block in the synthesis of pharmaceuticals or in medicinal chemistry research.
Biochemical activity
The presence of the dibenzylamino and hydroxypropyl groups suggests potential biochemical activity or reactivity.
Structural significance
The isoindoline-1,3-dione core may have structural or functional significance in pharmacological applications.
Research interest
The synthesis and characterization of 2-(3-(dibenzylamino)-2-hydroxypropyl)isoindoline-1,3-dione could be of interest to researchers in the fields of organic chemistry, medicinal chemistry, and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 170799-33-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,0,7,9 and 9 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 170799-33:
(8*1)+(7*7)+(6*0)+(5*7)+(4*9)+(3*9)+(2*3)+(1*3)=164
164 % 10 = 4
So 170799-33-4 is a valid CAS Registry Number.
170799-33-4Relevant academic research and scientific papers
SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS
-
Paragraph 0366; 0367, (2014/05/08)
Provided are pyridopyrazine compounds of formula (1), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, R4 and m are as defined in the specification.
Synthesis and biological activities of metabolites of mosapride, a new gastroprokinetic agent
Kato,Morie,Yoshida
, p. 699 - 702 (2007/10/02)
In order to confirm the proposed structures of two metabolites 3 and 4 of the gastroprokinetic agent mosapride [4-amino-5-chloro-2-ethoxy-N-{[4-(4-fluorobenzyl)-2 -morpholinyl]methyl}benzamide, 2], the compounds were synthesized and their biological activity was examined. The structures of the metabolites were confirmed by means of comparison with the synthetic compounds. The serotonin 5-HT4 receptor agonistic activities of the metabolites were found to be less than that of mosapride.
